Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Glaukos Corporation Common Stock (NY:GKOS)

97.10 -1.32 (-1.34%)
Streaming Delayed Price Updated: 2:15 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 478,304
Open 98.06
Bid (Size) 96.79 (2)
Ask (Size) 97.41 (2)
Prev. Close 98.42
Today's Range 94.25 - 98.39
52wk Range 88.16 - 163.71
Shares Outstanding 55,137,429
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much You Would Have Made Owning Glaukos Stock In The Last 5 Years
Via Benzinga
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
From Glaukos Corporation
Via Business Wire

Performance

YTD
-35.1%
-35.1%
1 Month
-11.0%
-11.0%
3 Month
-35.1%
-35.1%
6 Month
-25.5%
-25.5%
1 Year
+4.3%
+4.3%

More News

Read More
Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today
Via Benzinga
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
Via Benzinga
Exposures Product Safety
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
From Glaukos Corporation
Via Business Wire
Earnings Scheduled For February 20, 2025
Via Benzinga
Peering Into Glaukos's Recent Short Interest
Via Benzinga
Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?
Via Benzinga
Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill
How Is The Market Feeling About Glaukos?
Via Benzinga
$1000 Invested In Glaukos 5 Years Ago Would Be Worth This Much Today
Via Benzinga
What 11 Analyst Ratings Have To Say About Glaukos
Via Benzinga
(GKOS) - Analyzing Glaukos's Short Interest
Via Benzinga
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results
From Glaukos Corporation
Via Business Wire
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
From Glaukos Corporation
Via Business Wire
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
From Glaukos Corporation
Via Business Wire
How Is The Market Feeling About Glaukos?
Via Benzinga
Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market
Via Benzinga
Topics Fraud
Exposures Legal
Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday
Via Benzinga
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
From Glaukos Corporation
Via Business Wire
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
From Glaukos Corporation
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 7
Via Talk Markets
Topics Stocks / Equities
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga

Frequently Asked Questions

Is Glaukos Corporation Common Stock publicly traded?
Yes, Glaukos Corporation Common Stock is publicly traded.
What exchange does Glaukos Corporation Common Stock trade on?
Glaukos Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Glaukos Corporation Common Stock?
The ticker symbol for Glaukos Corporation Common Stock is GKOS on the New York Stock Exchange
What is the current price of Glaukos Corporation Common Stock?
The current price of Glaukos Corporation Common Stock is 97.10
When was Glaukos Corporation Common Stock last traded?
The last trade of Glaukos Corporation Common Stock was at 04/01/25 02:15 PM ET
What is the market capitalization of Glaukos Corporation Common Stock?
The market capitalization of Glaukos Corporation Common Stock is 5.35B
How many shares of Glaukos Corporation Common Stock are outstanding?
Glaukos Corporation Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.